No PBS listing for HIV prevention pill

The Pharmaceutical Benefits Advisory Committee has rejected an application to recommend the listing of a HIV prevention drug on the PBS.

HIV AIDS test – Getty Images

Truvada will not be listed on the PBS. (Getty Images) Source: Getty Images

A HIV prevention drug won't be taxpayer-subsidised after a committee decided not to recommend its listing on the Pharmaceutical Benefits Scheme.

An application to list Truvuda - a once-daily pill which costs around $750 a month and aimed at preventing HIV transmission - was rejected on Friday.

The Australian Federation of AIDS Organisations said it was disappointed with the decision, adding people were needlessly getting HIV while waiting to access the pill.

Advertisement



Share
1 min read
Published 19 August 2016 at 4:36pm
Source: AAP